Chris J Benmore
Overview
Explore the profile of Chris J Benmore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kassem M, Benmore C, Tverjanovich A, Bokova M, Khomenko M, Usuki T, et al.
ACS Appl Mater Interfaces
. 2025 Mar;
PMID: 40064514
Antimony sesquiselenide has become an outstanding functional material for photovoltaics, energy storage and transformation, memory and photonic applications. SbSe is one of the most successful emerging solar light absorbers and...
2.
Dinpajooh M, Biasin E, Nienhuis E, Mergelsberg S, Benmore C, Schenter G, et al.
J Chem Phys
. 2024 Oct;
161(15).
PMID: 39431448
We establish the connection between the measured small angle x-ray scattering signal and the charge-charge correlations underlying Kirkwood transitions (KTs) in 1:1, 2:1, and 3:1 aqueous electrolytes. These measurements allow...
3.
Benmore C, Sivaraman G
J Chem Phys
. 2024 Oct;
161(15).
PMID: 39404203
High energy x-ray pair distribution function measurements show the average coordination number of the first shell in liquid sulfur is 1.86 ± 0.04 across the λ-transition, not precisely 2.0 as...
4.
Wilke S, Al-Rubkhi A, Benmore C, Byrn S, Weber R
Mol Pharm
. 2024 Jul;
21(8):3967-3978.
PMID: 39018110
The metastability of amorphous formulations poses barriers to their safe and widespread commercialization. The propensity of amorphous solid dispersions (ASDs) to crystallize is directly linked to their molecular structure. Amorphous...
5.
Sivaraman G, Benmore C
J Phys Condens Matter
. 2024 Jun;
36(38).
PMID: 38866028
Bridging the gap between diffuse x-ray or neutron scattering measurements and predicted structures derived from atom-atom pair potentials in disordered materials, has been a longstanding challenge in condensed matter physics....
6.
Benmore C, Edwards A, Alderman O, Cherry B, Smith P, Smith D, et al.
Quantum Beam Sci
. 2024 May;
6(4).
PMID: 38765796
To enhance the solubility of orally administered pharmaceuticals, liquid capsules or amorphous tablets are often preferred over crystalline drug products. However, little is known regarding the variation in bonding mechanisms...
7.
Wilke S, Benmore C, Alderman O, Sivaraman G, Ruehl M, Hawthorne K, et al.
Nat Mater
. 2024 Apr;
23(7):884-889.
PMID: 38671164
Advances in nuclear power reactors include the use of mixed oxide fuel, containing uranium and plutonium oxides. The high-temperature behaviour and structure of PuO above 1,800 K remain largely unexplored,...
8.
Wilke S, Benmore C, Menon V, Smith D, Byrn S, Weber R
RSC Pharm
. 2024 Apr;
1(1):121-131.
PMID: 38646594
Amorphous solid dispersions (ASDs) are a widely studied formulation approach for improving the bioavailability of poorly water-soluble pharmaceuticals. Yet, a complete understanding remains lacking for how specific processing methods may...
9.
Wilke S, Al-Rubkhi A, Koyama C, Ishikawa T, Oda H, Topper B, et al.
NPJ Microgravity
. 2024 Mar;
10(1):26.
PMID: 38448495
The relationships between materials processing and structure can vary between terrestrial and reduced gravity environments. As one case study, we compare the nonequilibrium melt processing of a rare-earth titanate, nominally...
10.
Chen Z, Nie H, Benmore C, Smith P, Du Y, Byrn S, et al.
Mol Pharm
. 2023 Oct;
20(11):5763-5777.
PMID: 37800667
The structural investigation of amorphous pharmaceuticals is of paramount importance in comprehending their physicochemical stability. However, it has remained a relatively underexplored realm primarily due to the limited availability of...